TuHURA Biosciences, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $157.3M
- Price
- $2.47
- % Change (Daily % change from the live per-ticker quote feed.)
- +7.39%
- Volume
- 317.1K
About
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Quick stats
Shares outstanding63.7M
Computed float24.3M
Float / shares38.1%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001498382
Websitehttp://www.tuhurabio.com
AI Summary
AI-generated1/7
standardmixedearnings
TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
TuHURA filed an IND for TBS-2025 in AML and outlined 2H 2026 milestones, including potential orphan drug designations for IFx-2.0 and TBS-2025.
The company reported a cash balance of just $1.0 million at June 30, 2026, with total operating expenses of $8.7 million for the quarter.
To fund operations, TuHURA is utilizing a $50 million credit facility, having drawn $5.7 million to date, with an additional $2.15 million drawn subsequent to quarter-end.
Red flags
- Cash balance of $1.0M at quarter-end vs $8.7M quarterly burn rate
- 12% annual interest rate on credit facility